Post-Operative Accelerated-Hypofractionated Chemoradiation With Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost in Glioblastoma: A Phase I Study (ISIDE-BT-2)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Post-Operative Accelerated-Hypofractionated Chemoradiation With Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost in Glioblastoma: A Phase I Study (ISIDE-BT-2)
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-22
DOI
10.3389/fonc.2020.626400
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Therapies for Glioblastoma
- (2020) Elisa K. Liu et al. Current Neurology and Neuroscience Reports
- Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastoma
- (2019) Michelle M. Kim et al. JOURNAL OF NEURO-ONCOLOGY
- Prognostic analysis of patients who underwent gross total resection of newly diagnosed glioblastoma
- (2018) Masahide Matsuda et al. JOURNAL OF CLINICAL NEUROSCIENCE
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
- (2018) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma
- (2018) Sebastian Zschaeck et al. Radiation Oncology
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline
- (2017) Erik P. Sulman et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO)
- (2017) Silvia Scoccianti et al. Radiologia Medica
- Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study
- (2017) Ping Zhu et al. Oncotarget
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- A phase I dose escalation study using simultaneous integrated-boost IMRT with temozolomide in patients with unifocal glioblastoma
- (2016) G. Truc et al. Cancer Radiotherapie
- Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial
- (2016) Gabriella Macchia et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Dose-escalated intensity-modulated radiotherapy and irradiation of subventricular zones in relation to tumor control outcomes of patients with glioblastoma multiforme
- (2016) Melvin Chua et al. OncoTargets and Therapy
- Radiation Therapy Dose Escalation for Glioblastoma Multiforme in the Era of Temozolomide
- (2014) Shahed N. Badiyan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases
- (2013) Savino Cilla et al. Medical Dosimetry
- Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme
- (2013) Noha Jastaniyah et al. Radiation Oncology
- Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?
- (2012) M Hingorani et al. BRITISH JOURNAL OF RADIOLOGY
- Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1)
- (2012) Mariangela Massaccesi et al. International Journal of Clinical Oncology
- Phase II Trial of Hypofractionated IMRT With Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme
- (2012) Krishna Reddy et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Concurrent Temozolomide and Dose-Escalated Intensity-Modulated Radiation Therapy in Newly Diagnosed Glioblastoma
- (2011) C. I. Tsien et al. CLINICAL CANCER RESEARCH
- A Phase I Dose Escalation Study of Hypofractionated IMRT Field-in-Field Boost for Newly Diagnosed Glioblastoma Multiforme
- (2011) Arta M. Monjazeb et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase I Trial of Hypofractionated Intensity-Modulated Radiotherapy With Temozolomide Chemotherapy for Patients With Newly Diagnosed Glioblastoma Multiforme
- (2010) Changhu Chen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Intensity-modulated radiation therapy in newly diagnosed glioblastoma: A systematic review on clinical and technical issues
- (2010) Dante Amelio et al. RADIOTHERAPY AND ONCOLOGY
- A Phase I Dose-Escalation Study (ISIDE-BT-1) of Accelerated IMRT With Temozolomide in Patients With Glioblastoma
- (2009) Alessio G. Morganti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase I Three-Dimensional Conformal Radiation Dose Escalation Study in Newly Diagnosed Glioblastoma: Radiation Therapy Oncology Group Trial 98-03
- (2008) Christina Tsien et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started